Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

被引:1103
|
作者
Lipinski, Christopher A. [1 ]
Lombardo, Franco [1 ]
Dominy, Beryl W. [1 ]
Feeney, Paul J. [1 ]
机构
[1] Pfizer Inc, Div Cent Res, Groton, CT 06340 USA
关键词
Rule of 5; Computational alert; Poor absorption or permeation; MWT; MLogP; H-Bond donors and acceptors; Turbidimetric solubility; Thermodynamic solubility; Solubility calculation; WATER PARTITION-COEFFICIENTS; AQUEOUS SOLUBILITY; ORGANIC-COMPOUNDS; THEORETICAL DESCRIPTORS; MELTING-POINT; OCTANOL; PARAMETER; CONSTRUCTION; ABSORPTION; PREDICTION;
D O I
10.1016/j.addr.2012.09.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP>4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (FITS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements. (C) 2012 Published by Elsevier B.V.
引用
收藏
页码:4 / 17
页数:14
相关论文
共 50 条
  • [1] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    Central Research Division, Pfizer Inc., Groton, CT 06340, United States
    ADV. DRUG DELIV. REV., 1-3 (3-25):
  • [2] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    Lipinski, CA
    Lombardo, F
    Dominy, BW
    Feeney, PJ
    ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) : 3 - 25
  • [3] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997)
    Lipinski, CA
    Lombardo, F
    Dominy, BW
    Feeney, PJ
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 3 - 26
  • [4] Advances in Computational Approaches for Estimating Passive Permeability in Drug Discovery
    Bernardi, Austen
    Bennett, W. F. Drew
    He, Stewart
    Jones, Derek
    Kirshner, Dan
    Bennion, Brian J.
    Carpenter, Timothy S.
    MEMBRANES, 2023, 13 (11)
  • [5] Thermodynamic Approaches to the Challenges of Solubility in Drug Discovery and Development
    Perlovich, German L.
    MOLECULAR PHARMACEUTICS, 2014, 11 (01) : 1 - 11
  • [6] Computational Approaches in Preclinical Studies on Drug Discovery and Development
    Wu, Fengxu
    Zhou, Yuquan
    Li, Langhui
    Shen, Xianhuan
    Chen, Ganying
    Wang, Xiaoqing
    Liang, Xianyang
    Tan, Mengyuan
    Huang, Zunnan
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [7] Computational Approaches for Drug Discovery
    Brogi, Simone
    MOLECULES, 2019, 24 (17):
  • [8] Computational Approaches for Drug Discovery
    Hung, Che-Lun
    Chen, Chi-Chun
    DRUG DEVELOPMENT RESEARCH, 2014, 75 (06) : 412 - 418
  • [9] Computational approaches to determine drug solubility
    Faller, Bernard
    Ertl, Peter
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 533 - 545
  • [10] Solubility and Permeability Measurement and Applications in Drug Discovery
    Burton, Philip S.
    Goodwin, Jay T.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2010, 13 (02) : 101 - 111